Heart disease • Troy Media Digital Solutions

Remnant cholesterol significant risk factor for cardiovascular disease

Photo by Oleg Ivanov

“Bad” cholesterol not the only culprit linked to higher likelihood of heart disease

Machine learning predicts risk of death based on routine hospital tests

Computer analysis can help healthcare system “learn” by providing information vital to improving care

PCOS leading cause of menstrual dysfunction, infertility

Sarah Chambers hopes that sharing her experience with PCOS will help others get better diagnosis and treatment. (Photo: Supplied)

Polycystic ovary syndrome causes the ovaries to produce abnormally high levels of male hormones

Researchers pinpoint genetic defects that cause heart failure

Alberta heart donors critical for breakthrough research, pointing way to targeted treatments

Not enough men in their 40s get screened for diabetes: study

Undiagnosed, untreated illness could lead to heart disease later in life, says lead researcher

Eat less meat, save the environment and pay less at the grocery store

Flexitarians have decreased risk of heart disease and Type 2 diabetes and reduced risk of cancer

New devices could prevent a significant number of disabling strokes

An implantable device that monitors for atrial fibrillation over 12 months is more than three times more effective at detecting the condition than standard care, and could help prevent disabling strokes in patients, according to an Alberta clinical trial. (Photo: Supplied)

Results from clinical trial expected to significantly change how clinicians monitor for atrial fibrillation in stroke patients

U of A spinoff, U.S. firm merge to commercialize transplant technology

Cardiac surgery professors Jayan Nagendran (left) and Darren Freed with the EVOSS system they developed to extend the time donated lungs can be kept healthy while they are transported for transplant. The innovative technology took a major step toward approval, manufacture and global distribution with the merger of the U of A spinoff company Tevosol and the U.S.-based medical tech company Bridge to Life. (Photo: University Hospital Foundation)

Bridge to Life commits US$10 million to clinical trial and commercial development of Tevosol Ex-Vivo Organ Support System

Fat cells may influence how the body reacts to heart failure

Promising results in mice open door to new areas of research in treating patients with heart failure

Stents more effective for patients with stable high-risk heart disease

Photo by camilo jimenez on Unsplash

Location of blockages in a patient’s heart is a key consideration in selecting the right treatment, U of A cardiologists find

Tag: Heart disease